D-BMAP18 Antimicrobial Peptide Is Active In vitro, Resists to Pulmonary Proteases but Loses Its Activity in a Murine Model of Pseudomonas aeruginosa Lung Infection.

Front Chem · 2017 · PMC5474674 · PMID 28674688

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

A positive trend was found between D -BMAP18 dose and macroscopic damage, although it was not statistically significant because of the relevant data dispersion (Figure 4B ).

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

<i>D</i>-BMAP18 Antimicrobial Peptide Is Active <i>In vitro</i>, Resists to Pulmonary Proteases but Loses Its Activity in a Murine Model of <i>Pseudomonas aeruginosa</i> Lung Infection.

The sentences